Fig. 1From: Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literatureRatio of thyroglobulin (TG) to thyrotropin (TSH) [µg/mU] at selected points in time during follow-up. Black arrows mark the surgical interventions. White arrows mark the radioactive iodine (RAI) therapiesBack to article page